// App-Quantinova.ai

3818 : Therapeutic potential of blocking CCR5 by maraviroc in breast cancer bone metastasis

Researchers

Presenter

  • Asim Pervaiz

Principal Investigators

  • Michael Zepp

  • Doaa M. Ali

  • Martin R. Berger

  • Hassan Adwan

Medical Centers

  • Heidelberg University Hospital, Heidelberg, Germany

  • The German University at Cairo, Cairo, Egypt.

Locations

  • Germany

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bone metastases

  • Breast cancer

  • Solid malignancies

Biomarkers

  • C-C Motif Chemokine Receptor 5

Drug/Treatment

  • Maraviroc

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved